Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-086156
Filing Date
2024-10-08
Accepted
2024-10-08 12:08:21
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0215414-10q_bespoke.htm   iXBRL 10-Q 483792
2 CERTIFICATION ea021541401ex31-1_bespoke.htm EX-31.1 12337
3 CERTIFICATION ea021541401ex32-1_bespoke.htm EX-32.1 4352
  Complete submission text file 0001213900-24-086156.txt   4142483

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20240630.xsd EX-101.SCH 44494
5 XBRL CALCULATION FILE bspk-20240630_cal.xml EX-101.CAL 31912
6 XBRL DEFINITION FILE bspk-20240630_def.xml EX-101.DEF 245146
7 XBRL LABEL FILE bspk-20240630_lab.xml EX-101.LAB 428192
8 XBRL PRESENTATION FILE bspk-20240630_pre.xml EX-101.PRE 245339
59 EXTRACTED XBRL INSTANCE DOCUMENT ea0215414-10q_bespoke_htm.xml XML 323642
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 241359680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)